[go: up one dir, main page]

GB201707189D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB201707189D0
GB201707189D0 GBGB1707189.5A GB201707189A GB201707189D0 GB 201707189 D0 GB201707189 D0 GB 201707189D0 GB 201707189 A GB201707189 A GB 201707189A GB 201707189 D0 GB201707189 D0 GB 201707189D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1707189.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arecor Ltd
Original Assignee
Arecor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arecor Ltd filed Critical Arecor Ltd
Priority to GBGB1707189.5A priority Critical patent/GB201707189D0/en
Publication of GB201707189D0 publication Critical patent/GB201707189D0/en
Priority to EP18723925.6A priority patent/EP3618840B1/en
Priority to ES18723925T priority patent/ES2973374T3/en
Priority to PCT/GB2018/051177 priority patent/WO2018203059A1/en
Priority to US16/610,826 priority patent/US20200093895A1/en
Priority to CN201880029060.2A priority patent/CN110582285B/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB1707189.5A 2017-05-05 2017-05-05 Novel formulations Ceased GB201707189D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1707189.5A GB201707189D0 (en) 2017-05-05 2017-05-05 Novel formulations
EP18723925.6A EP3618840B1 (en) 2017-05-05 2018-05-03 Stable insulin formulations
ES18723925T ES2973374T3 (en) 2017-05-05 2018-05-03 Stable insulin formulations
PCT/GB2018/051177 WO2018203059A1 (en) 2017-05-05 2018-05-03 Stable insulin formulations
US16/610,826 US20200093895A1 (en) 2017-05-05 2018-05-03 Stable insulin formulations
CN201880029060.2A CN110582285B (en) 2017-05-05 2018-05-03 stable insulin preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1707189.5A GB201707189D0 (en) 2017-05-05 2017-05-05 Novel formulations

Publications (1)

Publication Number Publication Date
GB201707189D0 true GB201707189D0 (en) 2017-06-21

Family

ID=59065456

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1707189.5A Ceased GB201707189D0 (en) 2017-05-05 2017-05-05 Novel formulations

Country Status (6)

Country Link
US (1) US20200093895A1 (en)
EP (1) EP3618840B1 (en)
CN (1) CN110582285B (en)
ES (1) ES2973374T3 (en)
GB (1) GB201707189D0 (en)
WO (1) WO2018203059A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
IL265609B2 (en) 2016-09-29 2024-02-01 Arecor Ltd Aqueous liquid pharmaceutical formulation comprising insulin, ionic zinc, non-ionic surfactant and a medical device comprising the formulation
IL270975B2 (en) 2017-06-01 2024-02-01 Lilly Co Eli Rapid-acting insulin compositions
EP3773473A1 (en) * 2018-04-04 2021-02-17 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
WO2019193353A1 (en) * 2018-04-04 2019-10-10 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
IL277731B2 (en) * 2018-04-04 2024-03-01 Arecor Ltd A medical infusion pump system for administration of an insulin compound
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations
CN118924882A (en) * 2023-05-10 2024-11-12 上海仁会生物制药股份有限公司 Pharmaceutical composition and use thereof, method for improving storage stability of pharmaceutical composition
CN119405787A (en) * 2024-09-24 2025-02-11 广东东阳光生物制剂有限公司 A high-stability, high-concentration zinc-containing insulin preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JPH04502465A (en) 1988-12-23 1992-05-07 ノボ ノルディスク アクティーゼルスカブ human insulin analogue
IL93282A (en) 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogs
DE69019534T2 (en) 1989-12-21 1995-09-21 Novonordisk As INSULIN PREPARATIONS CONTAINING NICOTIC ACID OR NICOTINAMIDE.
US5866538A (en) 1996-06-20 1999-02-02 Novo Nordisk A/S Insulin preparations containing NaCl
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
GB0700523D0 (en) 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
WO2008152106A1 (en) * 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
KR101775000B1 (en) 2009-06-26 2017-09-04 노보 노르디스크 에이/에스 Preparation comprising insulin, nicotinamide and an amino acid
EP2590667A4 (en) 2010-07-07 2013-11-27 Biodel Inc COMPOSITIONS AND METHODS FOR THE MODULATION OF PHARMACOKINETICS AND PHARMACODYNAMIC INSULIN
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
BR112014025132A2 (en) * 2012-04-11 2017-07-11 Novo Nordisk As insulin formulations
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
JP6322642B2 (en) * 2012-11-13 2018-05-09 アドシア Fast-acting insulin preparation containing a substituted anionic compound
CA2889165A1 (en) * 2012-12-19 2014-06-26 Wockhardt Limited A stable aqueous composition comprising human insulin or an analogue or derivative thereof
BR112016016290A2 (en) * 2014-01-13 2017-10-03 Thermalin Diabetes Llc PHARMACEUTICAL COMPOSITIONS OF FAST-ACTING INSULIN, INFUSION SET, INFUSION SET SYSTEM AND USES OF MONOMER OR DIMERIC INSULIN ANALOGS
US20150273022A1 (en) 2014-02-10 2015-10-01 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
TWI685348B (en) 2014-05-08 2020-02-21 美國禮來大藥廠 Rapid-acting insulin compositions
GB201607918D0 (en) * 2016-05-06 2016-06-22 Arecor Ltd Novel formulations

Also Published As

Publication number Publication date
WO2018203059A1 (en) 2018-11-08
EP3618840B1 (en) 2023-12-27
US20200093895A1 (en) 2020-03-26
CN110582285B (en) 2023-04-14
CN110582285A (en) 2019-12-17
EP3618840C0 (en) 2023-12-27
EP3618840A1 (en) 2020-03-11
ES2973374T3 (en) 2024-06-19

Similar Documents

Publication Publication Date Title
IL273541A (en) Formulations
IL273282A (en) Niraparib formulations
IL269630A (en) Niraparib formulations
IL269621A (en) Niraparib formulations
IL265609A (en) Novel formulations
GB2600652B (en) Novel compositions
GB201607918D0 (en) Novel formulations
GB201707189D0 (en) Novel formulations
EP3373928A4 (en) Novel formulations
GB201809976D0 (en) Novel formulations
GB201701239D0 (en) Novel formulation
GB201707188D0 (en) Novel formulations
GB201718470D0 (en) Adhesive formulations
GB201707187D0 (en) Novel formulations
IL254075B (en) Durable pest-repelling formulations
GB201504482D0 (en) Novel formulations
IL268195A (en) Solid fosmetpantothenate formulations
GB201716291D0 (en) Novel formulations
SG11202011823SA (en) Activator-nucleator formulations
GB201707562D0 (en) Novel formulations
GB201707564D0 (en) Novel formulations
GB201707190D0 (en) Novel Formulations
GB201714461D0 (en) Formulations
GB201819028D0 (en) Butanol-based formulations
GB201808386D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)